Therapeutic Efficacy and Clinical Acceptability of Fusafungine* in Follicular Pharyngitis

References

• Schroeder HG. Die Pharyngitis und ihre verschiedenen klinischen Erscheinungsformen. [Pharyngitis and its various clinical manifestations]. Ther Umsch 1995;52:749–54
   PubMedGoogle Scholar
• Tarasov DI, Morozov AB. Chastota i struktura Khronicheskikh zabolevanii ukha, gorla i nosa sredi naselenia i ikh dinamika. [Frequency and structure of chronic diseases of ear, throat and nose among population and their dynamics] Vest Otorinolaringol 1991;2:12–14
   Google Scholar
• Pandraud L. La pharyngite granuleuse. Gaz Méd 1993;23: 40–3
   Google Scholar
• Bouche J, et al. Classification étiopathogénique des pharyngites chroniques. Ann Otolaryngol 1977;94:121–5
   Google Scholar
• Hahn R. Clinical evaluation of flurbiprofen alone and plus ampicillin in chronic pharyngitis in acute phase. Int J Clin Pharmacol Res 1986;6:81–6
   PubMedGoogle Scholar
• Hytiroglou P, Brandwein MS, Strauchen JA, Mirante JP, Urken ML, Biller HF. Inflammatory pseudotumor of the parapharyngeal space: case reports and review of the literature. Head Neck 1992;14:230–4
   PubMed Web of Science ®Google Scholar
• Wenig BM, Devaney K, Wenig BL. Pseudoneoplastic lesions of the oropharynx and larynx simulating cancer. Pathol Annu 1995;30(Pt 1):143–87
   PubMedGoogle Scholar
• Bassiouny A, el-Refai HA, Abdel Nabi EA, Fateen AM, Hendawy DS. Candida infection in the tongue and pharynx. J Laryngol Otol 1984;98:609–11
   PubMed Web of Science ®Google Scholar
• Falk G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae and chronic pharyngitis. Scand J Infect Dis 1995;27:179–82
   PubMed Web of Science ®Google Scholar
• Emmanueli JL. Infectious granulomatous diseases of the head and neck. Am J Otolaryngol 1993;1453:155–67
   Web of Science ®Google Scholar
• Peix JL, Moulin G, Evreux M, Berger N, Magis M. Localisations bucco-pharyngee et oesophagienne de la maladie de Crohn. Gastroenterol Clin Bio 1987;11:604–60
   PubMedGoogle Scholar
• Sechovic-Duric N. Znacaj izlozenosti radnika zaposlenih u kozarskoj industriji u prevalenciji obojenja gornjih respiratornih puteva [Significance of exposure of workers in the tanning industry and the prevalence of upper respiratory tract diseases]. Med Arh 1992;46:71–2
   PubMedGoogle Scholar
• Kanerva L, Makinen-Kiljunen S, Kiistala R, Granlund H. Occupational allergy caused by spathe flower (Spathiphyllum wallisii). Allergy 1995;50:174–8
   PubMed Web of Science ®Google Scholar
• Gluk U. Pollinossis und oral Allergiesyndrom (OAS) [Pollinosis and oral allergy syndrome]. HNO 1990;38:188–90
   PubMed Web of Science ®Google Scholar
• Kremser M. Nahrungsmittelallergien-orpharyngeale Reaktionen [Food allergies-oropharyngeal reactions]. Wien Med Wochenschr 1989;139:135–9
   PubMed Web of Science ®Google Scholar
• Drosnes DL, Zwillenberg DA. Laryngeal granulomatous polyp after short-term intubation of a child. Ann Otol Rhinol Laryngol 1990;99:183–6
   PubMed Web of Science ®Google Scholar
• Koltai P. effects of air pollution on the upper respiratory tract of children. Otolaryngol Head Neck Surg 1994;111:9–11
   PubMed Web of Science ®Google Scholar
• Murthy P, Laing MR. Cigarette smoking and throat pains in adults. Postgrad Med J 1995;71:510[Letter]
   PubMed Web of Science ®Google Scholar
• Cote DN, Miller RH. The association of gastroesophageal reflux and otolaryngologic disorders. Compr Ther 1995;21:80–4
   PubMedGoogle Scholar
• Olson NR. Laryngopharyngeal manifestations of gastroesophageal reflux disease. Otolaryngol Clin North Am 1991;24:1201–13
   PubMed Web of Science ®Google Scholar
• Rival R, Wong R, Mendelsohn M, Rosgen S, Goldberg M, Freeman J. Role of gastroesophageal reflux disease in patients with cervical symptoms. Otolaryngol Head Neck Surg 1995;113:364–9
   PubMed Web of Science ®Google Scholar
• Contencin P, Adjoua P, Viala P, Erminy M, Narcy P. La pH-métrie couplée, oesophagienne et oro/hypopharyngée, de longue durée dans les formes ORL de reflux gastrooesophagien de l’enfant. Ann Otolaryngol Chir Cervicofac 1992;109:129–33
   PubMedGoogle Scholar
• Pearlman NW, Stiegmann GV, Teter A. Primary upper aerodigestive tract manifestations of gastroesphageal reflux. Am J Gastroenterol 1988;83:22–5
   PubMed Web of Science ®Google Scholar
• Deschner WK, Benjamin SB, Extraesophageal manifestations of gastroesophageal reflux disease. Am J Gastroenterol 1989;84:1–5
   PubMed Web of Science ®Google Scholar
• Trotoux J, Angelard B, Aubert P. Manifestations ORL du reflux gastro-oesophagien. Rev Prat 1989;39:291–3
   PubMedGoogle Scholar
• Ward PH, Berci G. Observations on the pathogenesis of chronic non-specific pharyngitis and laryngitis. Laryngoscope 1982;92:1377–82
   PubMed Web of Science ®Google Scholar
• Kibblewhite DJ, Morrison MD. A double-blind controlled study of the efficacy of cimetidine in the treatment of the cervical symptoms of gastroesophageal reflux. J Otolaryngol 1990;19:103–9
   PubMedGoogle Scholar
• Zaidi SH. A study of H2 receptor antagonists in the treatment of chronic intractable pharyngitis. Pak Med Assoc 1990;40:217–19
   PubMedGoogle Scholar
• Lemercier JP. Locabiotal pressurisé et inflammation bronchique. Etude bronchoscopique et histopathologique. Vie Med 1976;57:2061–3
   Google Scholar
• White RR, Mattenberger L, Giessinger N. Activité anti-inflammatoire de la fusafungine: rôle des macrophages. Drugs Dis/Malad Medicam 1987;3(Suppl 1):57–62
   Google Scholar
• Guenant G. Rapidité d’action de Locabiotal pressurisé en monothérapie dans les rhino-sinusites débutantes. Drugs Dis/Malad Medicam 1988;4:105–12
   Google Scholar
• Gheam A, Harpey C. Evaluation de l’activité anti-inflammatoire de la fusafungine par rhinomanométrie. Etude à double insu contre placebo. Cah Oto-rhino-laryngol 1988;23(Suppl 4):25–8
   Google Scholar
• Nolibe D, Delage G, Thang MN. Activité antivirale de la fusafungine. Rhinology 1988;(Suppl 5):37–43
   PubMedGoogle Scholar
• Reinert P. Intérêt des test rapides pour la détection des infections streptococciques: illustration par une étude sur Locabiotal pressurisé dans les amygdalites. Malad Medicam 1989;5:97–104
   Google Scholar
• German-Fattal M, Le-Roy-Ladurie F, Cerrina J, Lecerf F, Berrih-Aknin S. Modulation of TNF-alpha expression in human alveolar macrophages in vitro by the anti-inflammatory drugs fusafungine and dexamethasone. Eur Respir J 1996;(Suppl. 9):2861
   Google Scholar
• Gosset P, Wallaert B, Crambes O, Girard V, Malbezin M, Tonnel AB. Fusafungine inhibits oxidative burst in macrophages during inflammatory response. Eur Respir J 1996;(Suppl 9):2860
   Google Scholar